Literature DB >> 11730720

Effects and mechanisms of aloe-emodin on cell death in human lung squamous cell carcinoma.

H Z Lee1, S L Hsu, M C Liu, C H Wu.   

Abstract

Aloe-emodin (1,8-dihydroxy-3-(hydroxymethyl)-anthraquinone) is an active component from the root and rhizome of Rheum palmatum. The study investigated the effects and mechanisms of aloe-emodin-induced cell death in human lung squamous cell carcinoma cell line CH27. Aloe-emodin (40 microM)-induced CH27 cell apoptosis was confirmed by DNA fragmentation (DNA ladders and sub-G(1) formation). Aloe-emodin-induced apoptosis of CH27 cells involved modulation of the expression of Bcl-2 family proteins, such as BclX(L), Bag-1, and Bak, and was associated with the translocation of Bak and Bax from cytosolic to particulate fractions. Aloe-emodin-treated CH27 cells had an increased relative abundance of cytochrome c in the cytosolic fraction. Results demonstrated that the activation of caspase-3, caspase-8, and caspase-9 is an important determinant of apoptotic death induced by aloe-emodin. These results suggest that aloe-emodin induces CH27 cell death by the Bax and Fas death pathway.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11730720     DOI: 10.1016/s0014-2999(01)01467-4

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  24 in total

1.  Emodin elicits cytotoxicity in human lung adenocarcinoma A549 cells through inducing apoptosis.

Authors:  Wing-Yan Li; Yam-Fung Ng; Huan Zhang; Zi-Dong Guo; De-Jian Guo; Yiu-Wa Kwan; George Pak-Heng Leung; Simon Ming-Yuen Lee; Peter Hoi-Fu Yu; Shun-Wan Chan
Journal:  Inflammopharmacology       Date:  2013-08-22       Impact factor: 4.473

2.  Modification of emodin and aloe-emodin by glycosylation in engineered Escherihia coli.

Authors:  Gopal Prasad Ghimire; Niranjan Koirala; Ramesh Prasad Pandey; Hye Jin Jung; Jae Kyung Sohng
Journal:  World J Microbiol Biotechnol       Date:  2015-02-07       Impact factor: 3.312

3.  Synergistic effect of rhein in combination with ampicillin or oxacillin against methicillin-resistant Staphylococcus aureus.

Authors:  Dae-Ki Joung; Hee Joung; DA-Wun Yang; Dong-Yeul Kwon; Jang-Gi Choi; Seo Woo; Dong-Young Shin; Oh-Hyun Kweon; Kee-Tae Kweon; Dong-Won Shin
Journal:  Exp Ther Med       Date:  2012-01-25       Impact factor: 2.447

4.  Acute effect of Aloe vera gel extract on experimental models of pain.

Authors:  Naveen Rathor; Ashish K Mehta; Amit K Sharma; Pramod K Mediratta; Krishna K Sharma
Journal:  Inflammation       Date:  2012-12       Impact factor: 4.092

5.  Anti-tumor effect of emodin on gynecological cancer cells.

Authors:  Yaoxian Wang; Hui Yu; Jin Zhang; Xin Ge; Jing Gao; Yunyan Zhang; Ge Lou
Journal:  Cell Oncol (Dordr)       Date:  2015-07-11       Impact factor: 6.730

6.  Design and evaluation of new chemotherapeutics of aloe-emodin (AE) against the deadly cancer disease: an in silico study.

Authors:  Chaitanya Mulakayala; Babajan Banaganapalli; Naveen Mulakayala; Madhusudana Pulaganti; Anuradha C M; Suresh Kumar Chitta
Journal:  J Chem Biol       Date:  2013-05-23

7.  Aloe-emodin, an anthraquinone, in vitro inhibits proliferation and induces apoptosis in human colon carcinoma cells.

Authors:  Kai-Yuan Lin; Yih-Huei Uen
Journal:  Oncol Lett       Date:  2010-05-01       Impact factor: 2.967

8.  Anti-cancer effects of aloe-emodin: a systematic review.

Authors:  Brian Sanders; Anna M Ray; Sharon Goldberg; Tyler Clark; H Reginald McDaniel; Steven E Atlas; Ashar Farooqi; Janet Konefal; Lucas C Lages; Johanna Lopez; Ammar Rasul; Eduard Tiozzo; Judi M Woolger; John E Lewis
Journal:  J Clin Transl Res       Date:  2017-09-07

Review 9.  Aloe and its Effects on Cancer: A Narrative Literature Review.

Authors:  Astère Manirakiza; Laurent Irakoze; Sebastien Manirakiza
Journal:  East Afr Health Res J       Date:  2021-06-11

10.  Formulation, antileukemia mechanism, pharmacokinetics, and biodistribution of a novel liposomal emodin.

Authors:  Tiechuang Wang; Xiaodong Yin; Yaping Lu; Weiguang Shan; Subin Xiong
Journal:  Int J Nanomedicine       Date:  2012-05-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.